News

Press Releases

  • August 5, 2020

    Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services

    View
  • August 4, 2020

    Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.

    View
  • November 19, 2019

    Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development

    View
  • June 18, 2019

    Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.

    View
  • January 1, 2016

    EPO Berlin-Buch GmbH announces strategic partnership for the American market: EPO starts strategic collaboration with NexusPharma to foster its market position in the USA

    View